Since the reduction of COX-2 in IPF fibroblast cultures is notable, we are tempted to speculate that these cells may respond to TGF-β1 treatment by increasing COX-1 expression to maintain basal COX metabolism. Here, TGFB1 is linked to idiopathic pulmonary fibrosis.